Search research articles
Contact Us
Filters
Showing results (101-110 of 115) with videos related to
Page
of 12
Sort By:
International Journal of Pharmaceutics
|
December 6, 2025
Are hydrophilic deep eutectic solvents a potential vehicle for topical delivery of Amphotericin B against cutaneous leishmaniasis? An investigation of physicochemical properties, tolerability and antileishmanial efficacy
Cảnh Hưng Nguyễn, Catherine Cailleau, Natalie Fournier, et al.
Molecular Diversity
|
October 17, 2022
Synthesis of new 3-acetyl-1,3,4-oxadiazolines combined with pyrimidines as antileishmanial and antiviral agents
Saida Lachhab, Az-Eddine El Mansouri, Ahmad Mehdi, et al.
Fitoterapia
|
October 15, 2015
Bioactive phloroglucinols from Mallotus oppositifolius
Faustin A Kabran, Timothée A Okpekon, François Roblot, et al.
Antimicrobial Agents and Chemotherapy
|
November 24, 2005
Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases
Hector Nakayama, Philippe M Loiseau, Christian Bories, et al.
ACS Omega
|
October 17, 2022
Design of Anti-infectious Agents from Lawsone in a Three-Component Reaction with Aldehydes and Isocyanides
Christina L Koumpoura, Michel Nguyen, Christian Bijani, et al.
Molecules (Basel, Switzerland)
|
November 3, 2020
Repurposing Auranofin and Evaluation of a New Gold(I) Compound for the Search of Treatment of Human and Cattle Parasitic Diseases: From Protozoa to Helminth Infections
Liwen Feng, Sébastien Pomel, Perle Latre de Late, et al.
The Journal of Infectious Diseases
|
April 18, 2015
VFV as a New Effective CYP51 Structure-Derived Drug Candidate for Chagas Disease and Visceral Leishmaniasis
Galina I Lepesheva, Tatiana Y Hargrove, Girish Rachakonda, et al.
Journal of Natural Products
|
March 11, 2017
Revisiting Previously Investigated Plants: A Molecular Networking-Based Study of Geissospermum laeve
Alexander E Fox Ramos, Charlotte Alcover, Laurent Evanno, et al.
Pharmaceutics
|
May 28, 2022
Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes
Guilherme S Ramos, Virgínia M R Vallejos, Gabriel S M Borges, et al.
Chemmedchem
|
December 17, 2024
Investigating the C2 Modulation of the Imidazo[1,2-a]pyrazine-Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition
Lhana Tisseur, Sandrine Cojean, Khadidiatou Gassama, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 115) with videos related to
Sort By:
Page
of 12
International Journal of Pharmaceutics
|
December 6, 2025
Are hydrophilic deep eutectic solvents a potential vehicle for topical delivery of Amphotericin B against cutaneous leishmaniasis? An investigation of physicochemical properties, tolerability and antileishmanial efficacy
Cảnh Hưng Nguyễn, Catherine Cailleau, Natalie Fournier, et al.
Molecular Diversity
|
October 17, 2022
Synthesis of new 3-acetyl-1,3,4-oxadiazolines combined with pyrimidines as antileishmanial and antiviral agents
Saida Lachhab, Az-Eddine El Mansouri, Ahmad Mehdi, et al.
Fitoterapia
|
October 15, 2015
Bioactive phloroglucinols from Mallotus oppositifolius
Faustin A Kabran, Timothée A Okpekon, François Roblot, et al.
Antimicrobial Agents and Chemotherapy
|
November 24, 2005
Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases
Hector Nakayama, Philippe M Loiseau, Christian Bories, et al.
ACS Omega
|
October 17, 2022
Design of Anti-infectious Agents from Lawsone in a Three-Component Reaction with Aldehydes and Isocyanides
Christina L Koumpoura, Michel Nguyen, Christian Bijani, et al.
Molecules (Basel, Switzerland)
|
November 3, 2020
Repurposing Auranofin and Evaluation of a New Gold(I) Compound for the Search of Treatment of Human and Cattle Parasitic Diseases: From Protozoa to Helminth Infections
Liwen Feng, Sébastien Pomel, Perle Latre de Late, et al.
The Journal of Infectious Diseases
|
April 18, 2015
VFV as a New Effective CYP51 Structure-Derived Drug Candidate for Chagas Disease and Visceral Leishmaniasis
Galina I Lepesheva, Tatiana Y Hargrove, Girish Rachakonda, et al.
Journal of Natural Products
|
March 11, 2017
Revisiting Previously Investigated Plants: A Molecular Networking-Based Study of Geissospermum laeve
Alexander E Fox Ramos, Charlotte Alcover, Laurent Evanno, et al.
Pharmaceutics
|
May 28, 2022
Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes
Guilherme S Ramos, Virgínia M R Vallejos, Gabriel S M Borges, et al.
Chemmedchem
|
December 17, 2024
Investigating the C2 Modulation of the Imidazo[1,2-a]pyrazine-Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition
Lhana Tisseur, Sandrine Cojean, Khadidiatou Gassama, et al.
Page
of 12